3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
76
Leukemia
43
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Leukemia, Myelomonocytic, Acute
16
Leukemia, Monocytic, Acute
16
Congenital Abnormalities
16
Leukemia, Megakaryoblastic, Acute
14
Leukemia, Erythroblastic, Acute
14
Myelodysplastic Syndromes
11
Leukemia, Promyelocytic, Acute
8
Leukemia, Myelomonocytic, Chronic
8
Anemia, Refractory, with Excess of Blasts
8
Recurrence
6
Myeloproliferative Disorders
5
Leukemia, Eosinophilic, Acute
5
Leukemia, Basophilic, Acute
4
Lymphoma
3
Leukemia, Myeloid, Chronic-Phase
3
Blast Crisis
3
Neutropenia
2
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Carcinoma, Hepatocellular
2
Thrombocythemia, Essential
1
Sarcoma, Synovial
1
Interventions
Doxorubicin
11
Ifosfamide
9
Radiotherapy
6
tazemetostat
4
pegfilgrastim
3
cixutumumab
3
Imatinib Mesylate
3
Filgrastim
3
Cyclophosphamide
3
pazopanib
2
Trabectedin
2
Sunitinib
2
Sorafenib
2
Etoposide
2
Dacarbazine
2
Chemotherapy, Adjuvant
2
trofosfamide
1
tremelimumab
1
temsirolimus
1
soblidotin
1
sargramostim
1
romidepsin
1
ribociclib
1
reolysin
1
poly ICLC
1
perifosine
1
pembrolizumab
1
lorvotuzumab mertansine
1
liposomal doxorubicin
1
ixabepilone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma, Synovial
×
Idarubicin
×
Clear all
NCT00876031
2022-11-08
CWS-2007-HR
University Hospital Tuebingen
Phase 3
Completed
195 enrolled